A pterygium (pl.: pterygia or pterygiums) is any wing-like triangular membrane occurring in the neck, eyes, knees, elbows, ankles or digits.[1]

Pterygium of the eye

The term comes from the Greek word pterygion meaning "wing".

Types

edit

Pterygium of the eye

edit

A pterygium reduces vision in several ways:

  1. Distortion of the corneal optics. This begins usually when the pterygium is greater than 2mm from the corneal limbus.
  2. Disruption of the tear. The tear film is the first lens in the eye. Pterygia are associated with eyelid inflammation, called blepharitis.
  3. Growth over the corneal centre, which leads to dramatic reduction of vision.
  4. Induced anterior corneal scarring, which often remains after surgical removal.

A pterygium of the eye grows very slowly. Usually it takes several years or decades to progress.

Surgical removal

edit

Indications for surgery, in order of decreasing importance:

  1. Growth over the corneal centre.
  2. Reduced vision due to corneal distortion.
  3. Documented growth.
  4. Symptoms of discomfort.
  5. Cosmesis.

Surgery is usually performed under local anaesthetic with light sedation as day surgery. The pterygium is stripped carefully off the surface of the eye. If this is all that is done, the pterygium regrows frequently. The technique with the lowest recurrence rate uses an autotransplantation of conjunctiva from under the eyelid. This is placed over the defect remaining from the removed pterygium. The graft can be stitched in place, which is time-consuming, and painful for the patient afterwards.

An alternative is the use of tissue adhesive fibrin glue. A Cochrane review including 14 studies and last updated October 2016, found that using fibrin glue when doing conjunctival autografting was associated with a reduced likelihood of the pterygium recurring compared with sutures.[3] The review found that operations may take less time but fibrin glue may be associated with more complications (for example, rupture, shrinking, inflammation,granuloma). A 3-year clinical study on the application of collagen matrix as excision site grafts showed significantly improved surgery success rates.[4]

The mechanism of the collagen matrix graft (commercially available as ologen) works by promoting healthy cell growth into the matrix, thus preventing conjunctiva overgrowth that can cover the iris.[5][6][7]

References

edit
  1. ^ Parikh SN, Crawford AH, Do TT, Roy DR (May 2004). "Popliteal pterygium syndrome: implications for orthopaedic management". Journal of Pediatric Orthopedics. Part B. 13 (3): 197–201. doi:10.1097/01202412-200405000-00010. PMID 15083121.
  2. ^ "pterygium historical control: Topics by Science.gov". www.science.gov. Retrieved 2024-10-25.
  3. ^ Romano V, Cruciani M, Conti L, Fontana L (December 2016). Cochrane Eyes and Vision Group (ed.). "Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery". The Cochrane Database of Systematic Reviews. 2016 (12): CD011308. doi:10.1002/14651858.CD011308.pub2. PMC 6463968. PMID 27911983.
  4. ^ "Archives Pterygium". Revista Brasileira de Oftalmologia. Retrieved 2024-10-25.
  5. ^ Cho CH, Lee SB (October 2015). "Biodegradable collagen matrix (Ologen™) implant and conjunctival autograft for scleral necrosis after pterygium excision: two case reports". BMC Ophthalmology. 15: 140. doi:10.1186/s12886-015-0130-z. PMC 4619331. PMID 26499993.
  6. ^ Rahman, I.; Said, D. G.; Maharajan, V. S.; Dua, H. S. (October 2010). "Amniotic membrane in ophthalmology: indications and limitations". Eye. 23 (10): 1954–1961. doi:10.1038/eye.2008.410. ISSN 1476-5454.
  7. ^ Shimazaki, Jun; Kosaka, Koichi; Shimmura, Shigeto; Tsubota, Kazuo (2003-01-01). "Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium". Ophthalmology. 110 (1): 119–124. doi:10.1016/S0161-6420(02)01453-7. ISSN 0161-6420.

Further reading

edit